Engineering an alkaline-stable protein A through rational design strategies

Area of Science:

• Biochemistry
• Protein Engineering
• Biopharmaceutical Manufacturing

Background:

• Monoclonal antibody drugs are crucial in biopharmaceuticals due to high specificity and low adverse reactions.
• Antibody purification constitutes a significant portion of production costs, with Protein A affinity chromatography being a common method.
• Improving the longevity and cost-effectiveness of Protein A chromatography, particularly its resistance to alkaline cleaning (CIP), is essential for reuse.

Purpose of the Study:

• To engineer an alkali-tolerant Protein A variant (4xPA-LPA) for enhanced Protein A affinity chromatography.
• To improve the stability and reusability of Protein A resins through targeted protein engineering.
• To reduce the overall cost of monoclonal antibody production by increasing the lifespan of purification media.

Main Methods:

• Semi-rational protein redesign based on bioinformatics, including surface charge analysis and linker peptide construction.
• Conserved site screening and mutagenesis guided by Multiple Sequence Alignment (MSA) and FoldX predictions.
• Characterization using SDS-PAGE, differential scanning calorimetry (DSC), and circular dichroism (CD) to assess stability and structural changes.

Main Results:

• The engineered 4xPA-LPA variant demonstrated significant alkali resistance, retaining over 84% of residues after 24 hours of 0.5 M NaOH treatment.
• Thermal stability increased, with a 2.47°C rise in Tm and enhanced alpha-helix content, indicating improved structural integrity.
• The variant maintained high binding capacity, with approximately 86% retention after alkali immersion and 89% after 100 simulated washing cycles.

Conclusions:

• The novel alkali-resistant Protein A (4xPA-LPA) shows promising applications for cost-effective monoclonal antibody purification.
• This engineered protein enhances the reusability of Protein A affinity chromatography resins.
• The study provides a strategic framework for future protein engineering efforts aimed at improving alkali-resistance in proteins.